News
ASBP
5.17
-6.34%
-0.35
Weekly Report: what happened at ASBP last week (0504-0508)?
Weekly Report · 2d ago
Upcoming Stock Splits This Week (May 11 to May 15) – Stay Invested
TipRanks · 2d ago
Aspire Biopharma Holdings Inc trading halted, news pending
TipRanks · 4d ago
Why Akamai Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Benzinga · 5d ago
Aspire Biopharma to effect 1-for-30 reverse stock split
TipRanks · 5d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 5d ago
Aspire Biopharma effects 1-for-30 reverse stock split May 11
PUBT · 5d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 5d ago
Why Kulicke And Soffa Industries Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
Benzinga · 6d ago
Weekly Report: what happened at ASBP last week (0427-0501)?
Weekly Report · 05/04 10:16
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 04/30 12:06
Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Benzinga · 04/30 09:26
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 04/29 21:06
Aspire Biopharma Shares Rise Over 6% On Repurchase Plan Or Pipeline Focus?
NASDAQ · 04/29 11:49
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 04/28 17:05
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 04/27 21:05
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 04/27 17:05
Aspire Biopharma announces $5M share repurchase plan
TipRanks · 04/27 12:40
Aspire Biopharma announces $5M share repurchase program
Seeking Alpha · 04/27 12:39
Aspire Biopharma Announces $5M Share Buyback Program
Benzinga · 04/27 12:32
More
Webull provides a variety of real-time ASBP stock news. You can receive the latest news about Aspire Biopharma Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About ASBP
Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company. It develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. It has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. It also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.